BRKR (STOCKS)
Bruker Corporation
$39.100000
+1.510000 (+4.02%)
Prev close: $37.590000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Frank H. Laukien
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $5,942.64M
- Employees
- 11,396
- P/E (TTM)
- -262.61
- P/B (TTM)
- 2.33
- Dividend Yield
- 53.21%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
8
Buy
6
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$0.59 | $0.66 | -0.0722 | -10.90% |
|
Sep 2025 (Q3)
|
$0.45 | $0.34 | +0.1083 | +31.69% |
|
Jun 2025 (Q2)
|
$0.32 | $0.43 | -0.1125 | -26.01% |
|
Mar 2025 (Q1)
|
$0.47 | $0.44 | +0.0290 | +6.58% |
Financial Statements
| Revenues | $3.44B |
| Benefits Costs and Expenses | $3.41B |
| Cost Of Revenue | $1.86B |
| Costs And Expenses | $3.41B |
| Gross Profit | $1.58B |
| Nonoperating Income/Loss | -$46.20M |
| Operating Expenses | $1.51B |
| Selling, General, and Administrative Expenses | $946.50M |
| Research and Development | $395.20M |
| Other Operating Expenses | $167.80M |
| Operating Income/Loss | $68.20M |
| Income/Loss From Continuing Operations After Tax | -$7.30M |
| Income/Loss From Continuing Operations Before Tax | $22.00M |
| Income Tax Expense/Benefit | $29.30M |
| Income Tax Expense/Benefit, Current | $133.70M |
| Income Tax Expense/Benefit, Deferred | -$104.50M |
| Net Income/Loss | -$8.30M |
| Net Income/Loss Attributable To Noncontrolling Interest | $300.00K |
| Net Income/Loss Attributable To Parent | -$8.60M |
| Net Income/Loss Available To Common Stockholders, Basic | -$22.50M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $13.90M |
| Preferred Stock Dividends And Other Adjustments | $13.90M |
| Basic Earnings Per Share | -$0.15 |
| Diluted Earnings Per Share | -$0.15 |
| Basic Average Shares | 151,800,000 |
| Diluted Average Shares | 151,800,000 |
| Assets | $6.24B |
| Current Assets | $2.21B |
| Inventory | $1.09B |
| Prepaid Expenses | $35.20M |
| Other Current Assets | $1.08B |
| Noncurrent Assets | $4.03B |
| Fixed Assets | $744.80M |
| Intangible Assets | $899.60M |
| Other Non-current Assets | $2.38B |
| Liabilities | $3.73B |
| Current Liabilities | $1.28B |
| Accounts Payable | $215.90M |
| Wages | $179.70M |
| Other Current Liabilities | $883.60M |
| Noncurrent Liabilities | $2.45B |
| Long-term Debt | $1.87B |
| Other Non-current Liabilities | $582.80M |
| Redeemable Noncontrolling Interest | $36.80M |
| Equity | $2.47B |
| Equity Attributable To Noncontrolling Interest | $17.00M |
| Equity Attributable To Parent | $2.46B |
| Temporary Equity | $36.80M |
| Liabilities And Equity | $6.24B |
| Net Cash Flow From Operating Activities | $134.10M |
| Net Cash Flow From Operating Activities, Continuing | $134.10M |
| Net Cash Flow From Investing Activities | -$196.50M |
| Net Cash Flow From Investing Activities, Continuing | -$196.50M |
| Net Cash Flow From Financing Activities | $135.10M |
| Net Cash Flow From Financing Activities, Continuing | $135.10M |
| Exchange Gains/Losses | $43.70M |
| Net Cash Flow | $116.40M |
| Net Cash Flow, Continuing | $72.70M |
| Comprehensive Income/Loss | $20.50M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $5.10M |
| Comprehensive Income/Loss Attributable To Parent | $15.40M |
| Other Comprehensive Income/Loss | $28.80M |
| Other Comprehensive Income/Loss Attributable To Parent | $28.80M |